Nexium
Product Images NDC 21695-092

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Nexium (NDC 21695-092). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rebel Distributors Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Chemiical Structure)

Chemical structure diagram of the active ingredient associated with NEXIUM, showing the molecular formula including Mg2+ and 3 H2O. The structure includes methoxy groups and nitrogen-containing rings, indicating a complex molecule consistent with esomeprazole magnesium.*

FDA Label Image

Figureone (Ea79f802 E9ac 480b 91e6 1e3900b11803 02)

A line graph depicting the percent maintained over six months for NEXIUM at doses of 40 mg, 20 mg, and 10 mg compared to placebo. The y-axis shows Percent Maintained, and the x-axis shows Months, illustrating higher maintenance rates for NEXIUM doses versus placebo over time.*

FDA Label Image

Figuretwo (Ea79f802 E9ac 480b 91e6 1e3900b11803 03)

A line graph showing the percent maintained over 6 months for NEXIUM at 40 mg, 20 mg, 10 mg, and a placebo. The y-axis represents percent maintained from 0 to 100%, and the x-axis represents months from 0 to 6. Data points reflect higher maintenance rates for NEXIUM 40 mg and 20 mg compared to 10 mg and placebo over time.*

FDA Label Image

Figurethree (Ea79f802 E9ac 480b 91e6 1e3900b11803 04)

A line graph showing the percent of patients symptom-free over a 28-day diary period. Three lines represent NEXIUM 40 mg, NEXIUM 20 mg, and placebo groups, with symptom-free percentages increasing over time, NEXIUM 40 mg and 20 mg generally outperforming placebo.*

FDA Label Image

Figurefour (Ea79f802 E9ac 480b 91e6 1e3900b11803 05)

A line graph depicting the percent of patients symptom-free over a 28-day diary period. It compares three groups: NEXIUM 40 mg, NEXIUM 20 mg, and a placebo, showing changes in symptom-free percentages across the days.*

FDA Label Image

Nexium 20mg (Ea79f802 E9ac 480b 91e6 1e3900b11803 06)

Nexium 20mg DR Capsules packaging label shows a 10-count bottle. Each delayed-release capsule contains 20mg of Esomeprazole. The capsules are described as opaque, hard gelatin, amethyst colored with two radial yellow bars on the cap and 'NEXIUM 20mg' in yellow on the body. The label also includes the NDC 21695-091-10, Physician Partner branding, and storage instructions at controlled room temperature. The product is manufactured by AstraZeneca AB, Sweden, and labeled by Rebel Distributors Corp.*

FDA Label Image

Nexium 40mg (Ea79f802 E9ac 480b 91e6 1e3900b11803 07)

NEXIUM 40mg DR Capsules label showing a bottle with 30 capsules. Each delayed-release capsule contains 40mg esomeprazole. The label includes storage instructions for controlled room temperature and warnings to keep medication out of children's reach. Distributed by Physician Partner, Thousand Oaks, CA.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.